Clicky

Heron Therapeutics, Inc. (HRTX) News

Date Title
Feb 13 Heron Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results On Thursday, February 27, 2025
Oct 2 Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Path To Profitability
Sep 25 Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")
Jul 25 While shareholders of Heron Therapeutics (NASDAQ:HRTX) are in the black over 1 year, those who bought a week ago aren't so fortunate
Jun 13 Avidity (RNA) Up 33% on Rare Muscle Disease Study Results
Jun 13 FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Jun 12 Viridian (VRDN) Up 10% on Clinical Updates for Eye Disease Drug
May 21 What Makes Heron Therapeutics (HRTX) a Strong Momentum Stock: Buy Now?
May 17 Ionis (IONS), Biogen Down on Ending Development of ALS Drug
May 15 FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
May 9 Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Released Its First-Quarter Earnings: Here's What Analysts Think
May 8 Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript
May 8 Heron Therapeutics First Quarter 2024 Earnings: Beats Expectations
May 8 Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Call Transcript Highlights: Significant ...
May 7 Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Overview: Surpasses Revenue Estimates
May 7 Heron Therapeutics (HRTX) Reports Q1 Earnings: What Key Metrics Have to Say
May 7 Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates
May 7 Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
May 2 Earnings Preview: Alpine Immune Sciences, Inc. (ALPN) Q1 Earnings Expected to Decline
Apr 30 Will Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know